News tagged with cholesterol drug
Related topics: food and drug administration
Shutting down a specific pathway in cancer cells appears to improve the ability of common drugs to wipe those cells out, according to new research from scientists at Fox Chase Cancer Center, published in the January issue ...
Cancer Jan 14, 2013 | 5 / 5 (2) | 0 |
Drugmaker Merck says it is suspending its sale of the cholesterol drug Tredaptive and is telling doctors to quit prescribing the medicine.
Medications Jan 11, 2013 | 1 / 5 (1) | 0
(HealthDay)—The U.S. Food and Drug Administration has approved the orphan drug Juxtapid (lomitapide) for patients with homozygous familial hypercholesterolemia (HoFH), for use in combination with a low-fat ...
Medications Dec 27, 2012 | not rated yet | 0
Small interfering RNAs (siRNAs) are a potent new drug class that can silence a disease-causing gene, but delivering them to a target cell can be challenging. An innovative delivery approach that dramatically ...
Medical research Dec 21, 2012 | 5 / 5 (2) | 0
(Medical Xpress)—It's the season of joy, peace and goodwill, but it's also the time of year that brings a spike in heart attacks with most occurring on Christmas Day, Boxing Day and New Year's Day.
Cardiology Dec 21, 2012 | 5 / 5 (2) | 0
Drugmaker Merck & Co. said it will not seek U.S. approval for its cholesterol drug Tredaptive and is recommending doctors abroad stop prescribing it to new patients, based on failed study results.
Medications Dec 20, 2012 | not rated yet | 0
Genetic susceptibility to anthracycline-related congestive heart failure (CHF) in survivors of hematopoietic cell transp
Researchers have identified specific genetic factors that are associated with heart failure in patients who have undergone hematopoietic stem cell transplantation (HCT) for blood cancer.
Medical research Dec 09, 2012 | not rated yet | 0
Children with HIV have a 2.5 fold increased risk of atherosclerosis, according to research presented at EUROECHO and other Imaging Modalities 2012. Antiretroviral treatment, lipid lowering drugs and prevention with healthy ...
HIV & AIDS Dec 05, 2012 | not rated yet | 0
Problem-plagued Ranbaxy Pharmaceuticals Inc. has halted production of generic cholesterol drug Lipitor while it investigates how tiny glass particles got into the ingredients used for dozens of batches of the drug that were ...
Medications Nov 30, 2012 | not rated yet | 0
(HealthDay)—People who exercise along with taking statins to lower their high cholesterol levels can dramatically reduce their risk of dying, a large new study suggests.
Cardiology Nov 28, 2012 | not rated yet | 1 |
More people are better off thanks to the impact of an influx of direct-to-consumer advertising spending than they would be without those marketing efforts, according to a study recently published by Jayani Jayawardhana, an ...
Medications Nov 26, 2012 | not rated yet | 0
(AP)—Ranbaxy Pharmaceuticals Inc. has recalled dozens of lots of its generic version of cholesterol drug Lipitor because some may contain tiny glass particles, the latest in a string of manufacturing deficiencies that once ...
Medications Nov 23, 2012 | not rated yet | 0
(HealthDay)—Xeljanz (tofacitinib) has been approved by the U.S. Food and Drug Administration to treat symptoms of rheumatoid arthritis (RA) among people who can't tolerate, or haven't been helped by, the drug methotrexate.
Arthritis & Rheumatism Nov 07, 2012 | not rated yet | 0
(HealthDay)—An experimental drug may help patients who can't tolerate statins lower their cholesterol, a new Australian study suggests.
Cardiology Nov 05, 2012 | 4 / 5 (3) | 0 |
In the United States, the cost paid for statins (drugs to lower cholesterol) in people under the age of 65 who have private insurance continues to exceed comparable costs paid by the government in the United Kingdom (U.K.) ...
Medications Nov 01, 2012 | 3.7 / 5 (3) | 1